Article Information
History
- December 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lucie Laot*,1,
- Enora Laas*,1,
- Noemie Girard1,
- Elise Dumas2,
- Eric Daoud2,
- Beatriz Grandal2,
- Jean-Yves Pierga3,
- Florence Coussy3,
- Youlia Kirova4,
- Elsy el Alam5,
- Guillaume Bataillon5,
- Marick Lae6,
- Florence Llouquet1,
- Fabien Reyal1,2,† and
- Anne-Sophie Hamy2
- 1Department of Surgical Oncology, Institut Curie, University Paris, 75005, Paris France
- 2Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, INSERM, University Paris, 75005, Paris, France
- 3Department of Medical Oncology, Institut Curie, University Paris, 75005 Paris, France
- 4Department of Radiotherapy, Institut Curie, University Paris, 75005 Paris, France
- 5Department of Tumor Biology, Institut Curie, University Paris, 75005 Paris, France
- 6Department of Pathology, Henri Becquerel Cancer Center, INSERM U1245, UniRouen Normandy University, Rouen, France
- ↵†Corresponding author:
Pr Fabien REYAL, Institut Curie, Department of Surgery, 26 rue d’Ulm, 75005 Paris, 00 33 615271980; fabien.reyal{at}curie.fr
↵* Contributed equally